Tumor-stroma interaction in orthotopic primary pancreatic cancer xenografts during hedgehog pathway inhibition

International Journal of Cancer

Volumn 133, Issue 1, 2013, Pages 225-234

  Chang, Qing ^a   Foltz, Warren D ^a,b   Chaudary, Naz ^a   Hill, Richard P ^a,c   Hedley, David W ^a,c  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Hedgehog pathway; magnetic resonance imaging; magnetization transfer; pancreatic cancer; primary xenograft

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 5E1; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOMATION; BIOLOGICAL MONITORING; CANCER INHIBITION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG TARGETING; FIBROSIS; GENE EXPRESSION; GENE TARGETING; HH GENE; HYBRIDOMA CELL CULTURE; IMAGE ANALYSIS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOTOPIC TRANSPLANTATION; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAINING; STROMA; TISSUE INTERACTION; TUMOR NECROSIS; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; CELL LINE, TUMOR; HEDGEHOG PROTEINS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MAGNETIC RESONANCE IMAGING; MICE; MICE, SCID; NEOPLASMS, EXPERIMENTAL; PANCREATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RNA, NEOPLASM; SIGNAL TRANSDUCTION; STROMAL CELLS; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84876664218     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28006     Document Type: Article

References (28)

1. Mahadevan D, Von Hoff DD,. Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mol Cancer Ther 2007; 6: 1186-97.
2. Mantoni TS, Lunardi S, Al-Assar O, et al. Pancreatic stellate cells radioprotect pancreatic cancer cells through beta1-integrin signaling. Cancer Res 2011; 71: 3453-8.
3. Vonlaufen A, Phillips PA, Xu Z, et al. Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance. Cancer Res 2008; 68: 7707-10.
4. Fendrich V, Esni F, Garay MV, et al. Hedgehog signaling is required for effective regeneration of exocrine pancreas. Gastroenterology 2008; 135: 621-31.
5. van den Brink GR,. Hedgehog signaling in development and homeostasis of the gastrointestinal tract. Physiol Rev 2007; 87: 1343-75.
6. Morton JP, Mongeau ME, Klimstra DS, et al. Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis. Proc Natl Acad Sci USA 2007; 104: 5103-8.
7. Morton JP, Lewis BC,. Shh signaling and pancreatic cancer: implications for therapy? Cell Cycle 2007; 6: 1553-7.
8. Berman DM, Karhadkar SS, Maitra A, et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003; 425: 846-51.
9. Yauch RL, Gould SE, Scales SJ, et al. A paracrine requirement for hedgehog signalling in cancer. Nature 2008; 455: 406-10.
10. Bailey JM, Swanson BJ, Hamada T, et al. Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin Cancer Res 2008; 14: 5995-6004.
11. Olive KP, Jacobetz MA, Davidson CJ, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009; 324: 1457-61.
12. Henkelman RM, Stanisz GJ, Graham SJ,. Magnetization transfer in MRI: a review. NMR Biomed 2001; 14: 57-64.
13. Li W, Zhang Z, Nicolai J, et al. Magnetization transfer MRI in pancreatic cancer xenograft models. Magn Reson Med 2012; 68: 1291-7.
14. Tofts PS,. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997; 7: 91-101.
15. Farace P, Merigo F, Fiorini S, et al. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content. Eur J Radiol 2011; 78: 52-9.
16. Ng SS, Tsao MS, Nicklee T, et al. Wortmannin inhibits pkb/akt phosphorylation and promotes gemcitabine antitumor activity in orthotopic human pancreatic cancer xenografts in immunodeficient mice. Clin Cancer Res 2001; 7: 3269-75.
17. Yau CY, Wheeler JJ, Sutton KL, et al. Inhibition of integrin-linked kinase by a selective small molecule inhibitor, QLT0254, inhibits the PI3K/PKB/mTOR, Stat3, and FKHR pathways and tumor growth, and enhances gemcitabine-induced apoptosis in human orthotopic primary pancreatic cancer xenografts. Cancer Res 2005; 65: 1497-504.
18. Cao P, Maira SM, Garcia-Echeverria C, et al. Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts. Br J Cancer 2009; 100: 1267-76.
19. Chang Q, Jurisica I, Do T, et al. Hypoxia predicts aggressive growth and spontaneous metastasis formation from orthotopically grown primary xenografts of human pancreatic cancer. Cancer Res 2011; 71: 3110-20.
20. Ericson J, Morton S, Kawakami A, et al. Two critical periods of Sonic Hedgehog signaling required for the specification of motor neuron identity. Cell 1996; 87: 661-73.
21. Wang LC, Liu ZY, Gambardella L, et al. Regular articles: conditional disruption of hedgehog signaling pathway defines its critical role in hair development and regeneration. J Invest Dermatol 2000; 114: 901-8.
22. Lee CJ, Dosch J, Simeone DM,. Pancreatic cancer stem cells. J Clin Oncol 2008; 26: 2806-12.
23. Chai JW, Lin YC, Chen JH, et al. In vivo magnetic resonance (MR) study of fatty liver: importance of intracellular ultrastructural alteration for MR tissue parameters change. J Magn Reson Imaging 2001; 14: 35-41.
24. Chen JH, Yeung HN, Lee SK, et al. Evaluation of liver diseases via MTC and contrast agent. J Magn Reson Imaging 1999; 9: 257-65.
25. Kim H, Booth CJ, Pinus AB, et al. Induced hepatic fibrosis in rats: hepatic steatosis, macromolecule content, perfusion parameters, and their correlations-preliminary MR imaging in rats. Radiology 2008; 247: 696-705.
26. Berry LR, Barck KH, Go MA, et al. Quantification of viable tumor microvascular characteristics by multispectral analysis. Magn Reson Med 2008; 60: 64-72.
27. Henning EC, Azuma C, Sotak CH, et al. Multispectral quantification of tissue types in a RIF-1 tumor model with histological validation. Part I. Magn Reson Med 2007; 57: 501-12.
28. Carano RA, Ross AL, Ross J, et al. Quantification of tumor tissue populations by multispectral analysis. Magn Reson Med 2004; 51: 542-51.